Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Volume 26 - Issue 2 - February 2013

Column

Diabetes Watch
01/24/2013
A myriad of products exists for the treatment of acute and chronic wounds. The primary goal with any of these products is rapid wound closure. Studies have shown that a lack of reduction in wound size at four weeks of treatment should...
A myriad of products exists for the treatment of acute and chronic wounds. The primary goal with any of these products is rapid wound closure. Studies have shown that a lack of reduction in wound size at four weeks of treatment should...
A myriad of products exists...
01/24/2013
Podiatry Today
News and Trends
01/24/2013
Two phase III studies, recently published in the Journal of the American Academy of Dermatology, say a new topical triazole antifungal may be a viable alternative to oral treatments for onychomycosis.
Two phase III studies, recently published in the Journal of the American Academy of Dermatology, say a new topical triazole antifungal may be a viable alternative to oral treatments for onychomycosis.
Two phase III studies, recently...
01/24/2013
Podiatry Today

Feature

Case Study
01/22/2013
Can an emerging topical hold promise for onychomycosis? This author takes a closer look in this case study of a 24-year-old patient with distal lateral subungual onychomycosis.
Can an emerging topical hold promise for onychomycosis? This author takes a closer look in this case study of a 24-year-old patient with distal lateral subungual onychomycosis.
Can an emerging topical hold...
01/22/2013
Podiatry Today

Advertisement

Advertisement